Epicure: efficacy of nintedanib as a treatment for epistaxis in HHT disease. A national, randomized, multicenter phase II study

被引：0

作者：

Hermann, R. ^{[1
]}

Fargeton, A. ^{[2
,3
]}

Decullier, E. ^{[4
]}

Chinet, T. ^{[5
]}

Corre, R. ^{[6
]}

Gilbert-Dussardier, B. ^{[7
]}

Grobost, V ^{[8
]}

Hatron, P. ^{[9
]}

Lavigne, C. ^{[10
]}

Leguy-Seguin, V ^{[11
]}

Parrot, A. ^{[12
]}

Riviere, S. ^{[13
]}

Seguier, J. ^{[14
]}

Beaudoin, M. ^{[2
,3
]}

Roux, A. ^{[4
]}

Bel, F. ^{[15
]}

Gervaise, C. ^{[15
]}

Faure, F. ^{[1
]}

Dupuis-Girod, S. ^{[2
,3
]}

机构：

[1] Hop Edouard Herriot, HCL, Serv ORL, Lyon, France

[2] Hop Femme Mere Enfant, HCL, Serv Genet, Bron, France

[3] Hop Femme Mere Enfant, HCL, Ctr Reference Malad Rendu Osler, Bron, France

[4] HCL, Unite Rech Clin, Pole Sante Publ, Lyon, France

[5] Hop Ambroise Pare, Serv Radiol & Pneumol Intervent, Boulogne Billancourt, France

[6] Hop Pontchaillou, Serv Pneumol, Rennes, France

[7] Hop J Bernard, Serv Genet, Poitiers, France

[8] CHU Estaing, Serv Med Interne, Clermont Ferrand, France

[9] Hop Jeanne de Flandre, Serv Med Interne, Lille, France

[10] CHU Angers, Serv Med Interne, Angers, France

[11] Hop Bocage, Serv Med Interne, Dijon, France

[12] Hop Tenon, Serv Imagerie & Radiol Intervent, Paris, France

[13] Hop St Eloi, Serv Med Interne, Montpellier, France

[14] Hop La Timone, Serv Med Interne, Marseille, France

[15] Grp Hosp Est, HCL, Pharm, Bron, France

来源：

ANGIOGENESIS | 2019年 / 22卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：629 / 630

页数：2

共 50 条

[31] A Multicenter, Double-Blind, Randomized Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Patients with Gaucher Disease.
Zimran, Ari
Emilio Gonzalez-Rodriguez, Derlis
Abrahamov, Aya
Elstein, Deborah
Heitner, Rene
Paz, Alona
Brill-Almon, Einat
Chertkoff, Raul
BLOOD, 2012, 120 (21)
[32] Phase II prospective study of radiosurgery for multiple CNS metastatic disease.
Kubicek, Greg J.
LaCouture, Tamara A.
Turtz, Alan
Patel, Ashish Bharat
Hughes, Lesley
Bexon, Anne
Xue, Jinyu
Choi, Micheal
Saraiya, Piya V.
Lerman, Nati
Asbell, Sucha O.
Goldman, Howard Warren
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[33] INFLUENCE OF INTERSTITIAL LUNG DISEASE DURATION ON THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS WITH ABATACEPT
Serrano-Combarro, A.
Atienza-Mateo, B.
Del-Val, N.
Ibarrola Paino, L.
Casafont-Sole, I.
Melero, R.
Perez Linaza, A.
Serrano-Garcia, I.
Castaneda, S.
Ortega Castro, R.
Calvo Gutierrez, J.
Mena-Vazquez, N.
Vegas-Revenga, N.
Dominguez Casas, L.
Delgado-Beltran, C.
Diez, C.
Perez Sandoval, T.
Retuerto-Guerrero, M.
Perez Albaladejo, L.
Lopez-Sanchez, R.
Mazano, M. G.
Brandy-Garcia, A.
Lopez Viejo, P.
Bonilla, G.
Maiz, O.
Carrasco Cubero, M. D. C.
Garijo Bufort, M.
Moreno, M.
Urruticoechea-Arana, A.
Ordonez, S.
Gonzalez-Montagut Gomez, C.
Peralta-Gines, C.
Osorio, M. C.
Canadillas, E.
De Dios Jimenez de Aberasturi, J. R.
Lozano Morillo, F.
Vazquez Rodriguez, T.
Carreira, P.
Blanco, J. M.
Fernandez-Diaz, C.
Loricera, J.
Ferraz-Amaro, I.
Ferrer, D.
Blanco, R.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 225 - 227
[34] Multicenter, Phase 2 exploratory study evaluating the safety and efficacy of DEXTENZA for the treatment of dry eye disease
Sheppard, J. D.
Torkildsen, G. L.
Metzinger, J. L.
Stein, L.
Ousler, G.
Goldstein, M. H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S320 - S320
[35] Efficacy of Vedolizumab in Crohn's Disease by Prior Treatment Failure in Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study
Hanauer, Stephen B.
Feagan, Brian G.
MacIntosh, Donald G.
Xu, Jing
Milch, Catherine
Fox, Irving
Smyth, Michael D.
GASTROENTEROLOGY, 2013, 144 (05) : S772 - S772
[36] A multicenter phase II study of docetaxel and vinorelbine in recurrent ovarian cancer: Activity in platinum-resistant, paclitaxel pretreated disease.
Aravantinos, G
Bafaloukos, D
Skarlos, D
Papadimitriou, C
Fountzilas, G
Kalofonos, H
Nikolaides, K
Linardou, H
Xiros, N
Dimopoulos, MA
ANNALS OF ONCOLOGY, 2000, 11 : 86 - 86
[37] Efficacy, Safety, and Tolerability of a Novel Cyclosporine, a Formulation for Dry Eye Disease: A Multicenter Phase II Clinical Study
Peng, Wen-Yan
Chen, Rong-Xin
Dai, Hong
Zhu, Lei
Li, Ying
Gao, Zi-Qing
Li, Xiao-Yi
Zhou, Shi-You
CLINICAL THERAPEUTICS, 2021, 43 (03) : 613 - 628
[38] Apremilast for Refractory Mucocutaneous Ulcers of Behcet's Disease. National Multicenter Study of 14 Cases
Atienza-Mateo, Belen
Luis Martin-Varillas, Jose
Loricera, Javier
Vegas-Revenga, Nuria
Dominguez-Casas, Lucia C.
Hernandez, Jose L.
Moriano, Clara
Dolores Garcia-Armario, Maria
Castelvi, Ivan
Sivera, Francisca
Calvo-Alen, Jaime
de la Morena, Isabel
Ortiz-Sanjuan, Francisco
Andres Roman-Ivorra, Jose
Perez-Gomez, Ana
Gonzalez-Vela, M. C.
Angel Gonzalez-Gay, Miguel
Blanco, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[39] A triple-blinded, randomized placebo-controlled, multicenter phase II study of efficacy and safety of VF-08, a Chinese herbal medicine mixture, in treatment of Parkinson's disease
Yeung, J. H. M.
Auyeung, M.
Cheung, Y. F.
Chan, J.
Ng, P. W.
Li, H. L.
Wong, K. S.
Mok, V.
MOVEMENT DISORDERS, 2009, 24 : S287 - S287
[40] TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial
Andorfer, K. E. C.
Seebauer, C. T.
Koller, M.
Zeman, F.
Berneburg, M.
Fischer, R.
Vielsmeier, V.
Bohr, C.
Kuehnel, T. S.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2022, 80 (03) : 307 - 315

← 1 2 3 4 5 →